Biomechanical Simulations of Bioprosthetic Heart Valve Deformations

Author(s):  
Wei Sun ◽  
Hengchu Cao ◽  
Jim Davidson ◽  
Michael Sacks

Previous research has suggested that the structural deterioration in porcine bioprosthetic heart valves (BHV) may be correlated with the regions of high tensile and bending stresses acting on the leaflets during opening and closing[1, 2]. Stress concentrations within the cusp can either directly accelerate tissue structural fatigue damage, or initiate calcification by causing structural disintegration, enabling multiple pathways of calcification that can lead to valve failure[3,4]. In the case of bovine pericardial heart valve prostheses, structural failure of the leaflets is rare but calcification has been observed. Although details of the process are unclear, it is generally assumed that the design of the pericardial valve, which gives a stress-reduced state of the leaflets, is likely to provide improved performance in long-term applications.

2000 ◽  
Author(s):  
Michael S. Sacks ◽  
Sanjay Kaushal ◽  
John E. Mayer

Abstract The need for improved heart valve prostheses is especially critical in pediatric applications, where growth and remodeling are essential. Tissue engineered heart valves (TEHV) have functioned in the pulmonary circulation of growing lambs for up to four months [1], and thus can potentially overcome limitations of current bioprosthetic heart valves. Despite these promising results, significant questions remain. In particular, the role of scaffold mechanical properties in optimal extra-cellular matrix development, as well as TEHV durability, are largely unexplored. We have previously demonstrated flexure testing as a sensitive and critical test for BHV tissue mechanical property evaluation [2]. The following study was conducted to determine the feasibility of using this technique to provide fundamental information required for optimizing TEHV scaffold designs.


Author(s):  
Sarah C. Vigmostad ◽  
H. S. Udaykumar ◽  
Jia Lu ◽  
Michael S. Sacks ◽  
K. B. Chandran

Bioprosthetic heart valves are valve replacements constructed from animal tissue. Although they are geometrically similar to native aortic valves and offer comparable hemodynamic characteristics in their function, they have limited operational life, often requiring replacement 10–15 years after implantation. Though much is still unknown about bioprosthetic heart valve failure, it is generally accepted that this failure is to some extent due to structural decomposition. Although the mechanism for degradation is not clearly understood, it has been observed that these regions of failure are typically in locations where the leaflet undergoes large flexion and high compressive and tensile stresses [1]. An understanding of bioprosthetic heart valve failure necessitates detailed quantitative information on the complex motion of and the stresses on the leaflets particularly during the opening and closing phases and their relationship to structural failure.


2021 ◽  
Author(s):  
Mengyue Hu ◽  
Xu Peng ◽  
Yang Zhao ◽  
Xiaoshuang Yu ◽  
Can Cheng ◽  
...  

To conveniently and effectively cure heart valve diseases or defects, combining with transcatheter valve technology, bioprosthetic heart valves (BHVs) originated from the decellularized porcine pericardium (D-PP) have been broadly used...


Author(s):  
Scott C. Corbett ◽  
Hamid N.-Hashemi ◽  
Ahmet U. Coskun

While heart valve prostheses have been used successfully since 1960, outcomes are far from ideal. The underlying problem with bioprostheses is a limited life from structural changes such as calcification and leaflet wear, leading to valve failure. The underlying problem with mechanical heart valves is the presence of flow disturbances which necessitate anticoagulation. A polyurethane valve has the potential to improve upon the shortcomings of existing valves and ultimately improve patient survival.


Author(s):  
Sarah C. Vigmostad ◽  
Brian D. Jeffrey ◽  
Sreedevi Krishnan ◽  
H. S. Udaykumar ◽  
K. B. Chandran

Bioprosthetic heart valves are valve replacements constructed from animal tissue. They are deformable and offer similar mechanical properties to their native counterpart. While tearing of these valves is frequently observed, it is still not fully understood, but may be the result of high induced bending and shear stresses in the valve leaflets[1].


Author(s):  
Scott C. Corbett ◽  
Neil Verma ◽  
Parnian Boloori Zadeh ◽  
Ahmet U. Coskun ◽  
Hamid N.-Hashemi

While heart valve prostheses have been used successfully since 1960, 10-year survival rates still range from 37–58% [1]. The underlying problem with bioprostheses is a limited life from structural changes such as calcification and leaflet wear, leading to valve failure [2]. Biological tissue fixation and methods used to mount the tissue to a supporting stent can be blamed for this shortcoming. The underlying problem with mechanical heart valves is the presence of a centrally located leaflet, or occluder. It propagates high velocity jets, turbulence and areas of stagnation: the disturbances which necessitate anticoagulation [3]. A polyurethane valve has the potential to improve upon the shortcomings of existing valves and ultimately improve patient survival.


2012 ◽  
Vol 61 (5) ◽  
pp. 10-24
Author(s):  
Aleksandr Davidovich Makatsariya ◽  
Viktoriya Omarovna Bitsadze ◽  
Dzhamilya Khizriyevna Khizroyeva ◽  
Vyacheslav Borisovich Nemirovskiy ◽  
Svetlana Vladimirovna Akinshina

In patients with prosthetic heart valves pregnancy and labor are associated with high risk. There are no established anticoagulation guidelines in pregnant women with mechanical heart valve prostheses. More often physiological hypercoagulable state during pregnancy can reveal acquired and/or inherited hemostasis abnormalities which were asymptotic before pregnancy. The presence in the history of patients the foetal loss syndrome, severe obstetric complications (severe preeclampsia, abruptio placenta, antenatal fetal death, feto-placental insufficiency), thrombosis events is an indication for the screening for genetic thrombophilia and antiphospholipid syndrome. The diagnosis of thrombophilia in patients with mechanical heart valve prostheses can explain the inefficiency of anticoagulation therapy, warfarin resistance, «floating» hemostasis markers and difficulties in adequate dose selection


Author(s):  
M. A. Rezvova ◽  
E. A. Ovcharenko

The idea of creating a polymer heart valve, which has high strength and biocompatibility, occurs in the 60’s. Since then, many polymer compounds have been investigated, but no solution has been found for this problem. In recent years, in connection with the development of technologies for the synthesis of high-molecular compounds, new polymers have appeared that can solve this problem, as evidenced by a number of publications describing experimental and clinical data. Nevertheless, the search for a polymer for the valve stem of the valvular valve body does not lose its relevance due to the defi ciencies studied and the lack of evidence confi rming the long-term safety of such products. This review presents the fi rst results of a study of polymer heart valves prostheses based on a nanocomposite polymer from polyhedral oligomeric nanoparticles of silicosioxane and polycarbonate urethane polymer POSS-PCU, polystyrene block-isobutylene-block-styrene SIBS, PTFE polytetrafl uoroethylene, copolymers and composites based on olefi n polymers series and polyesters, the idea of creating a material with a given three-dimensional microarchitecture that determines the anisotropy and the necessary mechanical properties.


2020 ◽  
Vol 21 (Supplement_1) ◽  
Author(s):  
A Almaghraby ◽  
M Abdelnabi ◽  
Y Saleh ◽  
O Abdelkarim ◽  
O Ozden Tok ◽  
...  

Abstract OnBehalf YIG-CVR Introduction Thromboembolic events or bleeding are by far the most frequent complications of prosthetic heart valves. Cerebrovascular stroke is one of the major thromboembolic complications of anticoagulation-related issues of prosthetic heart valves. Aim of the work To determine the pattern and risk factors of acute stroke in patients with prosthetic heart valves. Methods and Patients A retrospective single-center analysis of the database registry of consecutive acute stroke patients with mitral or aortic heart valve prostheses admitted to a tertiary care stroke specialized center from 01/01/2012 to 01/12/2017. All patients were examined by a certified neurologist and underwent a complete work-up evaluation (Computed Tomography or Magnetic Resonance Imaging, Carotid Doppler ultrasound examination, complete blood tests, and electrocardiogram) and a transthoracic echocardiography (TTE) examination as well as transesophageal echocardiography (TOE) if valve dysfunction or thrombosis were suspected. Results 214 patients with mitral or aortic valve prostheses were admitted by acute stroke in the duration from 01/01/2012 to 01/12/2017 with a mean age of 44 ± 15 years, 132 were males (61.7%) and 178 patients had mechanical valves (83.2%). 135 patients had mitral prosthesis (63.1%) and ischemic stroke was encountered in 151 patients (70.6%). Conclusion In a single center experience, mechanical prosthesis at the mitral valve position was associated with higher incidence of ischemic stroke. Proper close follow-up of INR levels as well as the surgical shift to biological instead of mechanical valve should decrease significantly the incidence of prosthetic valve related strokes. Baseline, clinical and other parameters Patients (n = 214) Age (years) 44 ± 15 Mechanical valve 178 (83.2%) Atrial Fibrillation 101 (47.2%) Rheumatic Heart Disease 175 (81.8%) Left ventricular ejection fraction (%) 54 ±13 Mitral Only 135 (63.1%) Aortic Only 51 (23.8%) Double Valve Prosthesis 28 (13.1%) Ischemic stroke 151 (70.6%) Hemorrhagic stroke 47 (22%) Both ischemic and hemorrhagic stroke 16 (7.4%) Data are represented as mean(±SD) or number (Percentage) Abstract P1521 Figure. Valve sites


1966 ◽  
Vol 39 (4) ◽  
pp. 1276-1287 ◽  
Author(s):  
D. A. Raible ◽  
D. P. Keller ◽  
W. R. Pierie ◽  
S. Koorajian ◽  
E. G. Partridge

Abstract Approximately 0.1 per cent of silicone rubber balls from the estimated 18,000 implanted Starr-Edwards heart valve prostheses have been found to be variant. This material variation has initiated investigations of present material and accelerated the search for new and improved elastomers. Descriptions of various types of artificial heart valve prostheses, environmental conditions, design requirements and test apparatus are presented. Variant balls exhibit external physical damage by surface grooves and splits. Internal changes and discolorations from absorbed lipid materials have also been observed. Variant silicone rubber balls have poor physical properties compared with nonvariant or non-implanted balls. This reduction lowers the resistance to damage. The engineering laboratory evaluation program of elastomeric materials includes the compilation of test data on balls molded from silicone, butyl, ethylene propylene, polybutadiene and chlorohydrin rubbers. Butyl and polybutadiene rubbers were selected to demonstrate the extremes of the resilience spectrum with respect to the hydraulic performance of the ball type prosthesis. Compounds with low resilience for less ball rebound appear to be advantageous in this application To date, butyl rubber has exhibited excellent wear resistance in laboratory durability testers.


Sign in / Sign up

Export Citation Format

Share Document